Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Conditions

• Pneumococcal Disease

Interventions

• OTHER: Candidate-1
• OTHER: Candidate-2
• OTHER: Candidate-3
• OTHER: Candidate-4
• OTHER: Candidate-5
• OTHER: Candidate-6
• OTHER: Candidate Control
• BIOLOGICAL: 13vPnC
• BIOLOGICAL: PCV15

Sponsor

Pfizer